Loading member…
Loading the current profile and starting clinical evidence in parallel.
Loading current member data…
Clinical sections will appear as soon as their route-scoped read completes.
Loading the current profile and starting clinical evidence in parallel.
Loading current member data…
Clinical sections will appear as soon as their route-scoped read completes.
| Date | Type | Clinical activity | Evidence |
|---|---|---|---|
| 2026-08-02 | APPOINTMENT | Virtual · scheduled · booked 2026-07-14 · 19 days lead | appt›
|
| 2026-07-14 | ENCOUNTER | Annual physical · verified · in-person · DX E11.9, I10, E78.5 · CPT 99396, 99214 · Blood pressure 132/84 mmHg · Weight 198 lb · BMI 29.1 · labs attached | note · appt · labs · vitals›
|
| 2026-07-10 | LAB | lipids, CMP, CBC · LDL 118 · total chol 204 · HDL 44 · triglycerides 168 · TSH conflicted · CPT 80053, 85025 | results›
|
| 2026-07-02 | LAB | hsCRP · hsCRP 3.4 mg/L — source-quiet, guideline-flagged | results›
|
| 2026-06-30 | MEDICATION | Atorvastatin 40 mg · Lisinopril 10 mg | 2 orders›
|
| 2026-05-19 | APPOINTMENT | In-person · cancelled · booked 2026-04-28 · 21 days lead | cancellation fact›
|
| 2026-05-19 | EVIDENCE | Diagnosis candidate · unverified · billing source | held›
|
| 2026-01-08 | ENCOUNTER | Follow-up · verified · virtual · DX E11.9, I10 · CPT 99213 · Blood pressure 128/82 mmHg · Weight 201 lb · BMI 29.5 | vitals›
|
| 2025-11-03 | APPOINTMENT | In-person · no-show · booked 2025-10-06 · 28 days lead | no-show fact›
|
| 2025-07-02 | ENCOUNTER | Annual physical · verified · in-person · DX E11.9, I10 · CPT 99396, 99214 · Blood pressure 140/90 mmHg · Weight 205 lb · BMI 30.1 · labs attached | labs · vitals›
|
| 2025-04-10 | LAB | A1c · A1c 6.1% — source-quiet, above the 2025 guideline threshold | results›
|
| 2023-02-10 | LAB | renal panel · creatinine 1.1 · eGFR observed but unmapped | results›
|
| 2021-03-01 | ELIGIBILITY | Northstar Fabrication · primary member · replaced the prior Marathon eligibility period | eligibility |
| Date | Type | Clinical activity | Evidence |
|---|---|---|---|
| Undated | EVIDENCE | Unattached note pointer · ambiguous · unverified | note pointer›
|
| Condition | Evidence span | Posture | Evidence |
|---|---|---|---|
| Type 2 diabetes mellitus | May 22–Jul 26 | Current | E11.9 · metabolic · Problem list · 6 claimsType 2 diabetes mellitus Exact posture: current_active Condition evidence: EHR problem list + claims dx (kept distinct) Claims context: 6 rows · best rank 1 · most recent Jul 2, 2025 |
| Essential hypertension | Sep 21–Jul 26 | Current | I10 · cardiovascular · Problem list · 4 claimsEssential hypertension Exact posture: current_active Condition evidence: EHR problem list Claims context: 4 rows · best rank 1 · most recent Jul 2, 2025 |
| Medication | Evidence span | Posture | Evidence |
|---|---|---|---|
| Atorvastatin 40 mg | Feb 24–Jun 26 | Current | statin · oral tablet · Verve orderAtorvastatin 40 mg Exact posture: current candidate Source: Verve EHR order Safety posture: no governed safety flag |
| Lisinopril 10 mg | Aug 23–Jun 26 | Current | antihypertensive · oral tablet · Verve orderLisinopril 10 mg Exact posture: current candidate Source: Verve EHR order Safety posture: no governed safety flag |
| Biomarker | Latest | Lab | Guideline | Risk v1 | Trend |
|---|---|---|---|---|---|
Hemoglobin A1cHemoglobin A1cLatest: 6.1 % · Apr 10, 2025 · Verve EHR LAB: within ref Guideline: above threshold (2025) Risk v1: 5.81–6.2 · governed v1 band · 0.30 History: May 2, 2024 · 6.3 % → Nov 8, 2024 · 5.9 % → Apr 10, 2025 · 6.1 % Notes: Three lenses disagree and all three render. No care-gap or follow-up implication is drawn — cadence governance is pending. · LAB numeric range withheld because the supplied source flag conflicts with the source posture. | 6.1 % · Apr 10, 2025 · Verve | within ref | above threshold (2025) | 5.81–6.2.30 | 3 |
LDL cholesterolLDL cholesterolLatest: 118 mg/dL · Jul 10 · Verve EHR LAB: <100 · above ref (posture) · H Guideline: not wired Risk v1: 100–119.99 · governed v1 band · 0.10 History: Jul 2, 2025 · 131 mg/dL → Jul 10 · 118 mg/dL | 118 mg/dL · Jul 10 · Verve | <100Habove ref (posture) | not wired | 100–119.99.10 | 2 |
hsCRPhsCRPLatest: 3.4 mg/L · Jul 2 · Verve EHR LAB: not flagged (source-quiet) Guideline: above hs-CV threshold Risk v1: 3.01–6 · governed v1 band · 0.50 History: Jun 30, 2025 · 4.1 mg/L → Jul 2 · 3.4 mg/L Notes: Source-quiet but guideline-flagged: the lab did not flag it and the guideline lens did. Both render. · duplicate observation key on 2025-06-30 — row vs distinct posture shown, never silently collapsed | 3.4 mg/L · Jul 2 · Verve | not flagged (source-quiet) | above hs-CV threshold | 3.01–6.50 | 2 |
TriglyceridesTriglyceridesLatest: 168 mg/dL · Jul 10 · Verve EHR LAB: <150 · above ref (posture) · H Guideline: above threshold Risk v1: 150–199.99 · governed v1 band · 0.30 History: May 2, 2024 · 181 mg/dL → Jul 2, 2025 · 154 mg/dL → Jul 10 · 168 mg/dL | 168 mg/dL · Jul 10 · Verve | <150Habove ref (posture) | above threshold | 150–199.99.30 | 3 |
Total cholesterolTotal cholesterolLatest: 204 mg/dL · Jul 10 · Verve EHR LAB: above ref (posture) Guideline: not wired Risk v1: 180–259.99 · governed v1 band · 0.00 History: May 2, 2024 · 208 mg/dL → Jul 2, 2025 · 212 mg/dL → Jul 10 · 204 mg/dL | 204 mg/dL · Jul 10 · Verve | above ref (posture) | not wired | 180–259.99.00 | 3 |
HDL cholesterolHDL cholesterolLatest: 44 mg/dL · Jul 10 · Verve EHR LAB: >40 · within ref Guideline: not wired Risk v1: 40–44.99 · governed v1 band · 0.20 History: May 2, 2024 · 45 mg/dL → Jul 2, 2025 · 42 mg/dL → Jul 10 · 44 mg/dL | 44 mg/dL · Jul 10 · Verve | >40within ref | not wired | 40–44.99.20 | 3 |
CreatinineCreatinineLatest: 1.1 mg/dL · Feb 10, 2023 · Marathon lab LAB: within ref Guideline: not wired Risk v1: 1.1–1.49 · governed v1 band · 0.10 History: Mar 4, 2022 · 1.0 mg/dL → Feb 10, 2023 · 1.1 mg/dL Notes: Not classified stale — cadence governance is pending for this item. | 1.1 mg/dL · Feb 10, 2023 · Marathon | within ref | not wired | 1.1–1.49.10 | 2 |
TSHTSHLatest: 2.4 / 3.9 mIU/L · Jul 10 · Verve EHR LAB: not evaluable Guideline: not wired Risk v1: excluded — conflicted observation History: Jul 10 · 3.9 mIU/L → Jul 10 · 2.4 mIU/L Notes: Two source values on the same day. Conflicted evidence contributes to observed coverage and never resolves itself into one value on the reading surface. · conflicted — a second source value of 3.9 carries the same date · conflicted — two same-day source values, kept distinct | Conflicted · 2 values · Jul 10 | not evaluable | not wired | excluded — conflicted observation | 2 sources |
| Biomarker | Latest | Lab | Guideline | Risk v1 | Trend |
|---|---|---|---|---|---|
| Vitals & biometrics3/4 observed1 gapsGL 0Risk 0/0 | |||||
Blood pressureBlood pressureLatest: 132/84 mmHg · Jul 14 LAB: elevated (posture) Guideline: not wired Risk v1: not in v1 score output History: No observed history | 132/84 mmHg · Jul 14 | elevated (posture) | not wired | not in v1 score output | — |
Body weightBody weightLatest: 198 lb · Jul 14 LAB: none Guideline: not wired Risk v1: not in v1 score output History: No observed history | 198 lb · Jul 14 | none | not wired | not in v1 score output | — |
BMIBMILatest: 29.1 · Jul 14 LAB: elevated (observation posture) Guideline: not wired Risk v1: not in v1 score output History: No observed history Notes: Observation posture only — not a risk verdict. | 29.1 · Jul 14 | elevated (observation posture) | not wired | not in v1 score output | — |
Heart rateHeart rateLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
| Metabolic & glycemic2/4 observed2 gapsGL 1Risk 2/2 | |||||
Hemoglobin A1cHemoglobin A1cLatest: 6.1 % · Apr 10, 2025 · Verve EHR LAB: within ref Guideline: above threshold (2025) Risk v1: 5.81–6.2 · governed v1 band · 0.30 History: May 2, 2024 · 6.3 % → Nov 8, 2024 · 5.9 % → Apr 10, 2025 · 6.1 % Notes: Three lenses disagree and all three render. No care-gap or follow-up implication is drawn — cadence governance is pending. · LAB numeric range withheld because the supplied source flag conflicts with the source posture. | 6.1 % · Apr 10, 2025 · Verve | within ref | above threshold (2025) | 5.81–6.2.30 | 3 |
GlucoseGlucoseLatest: 104 mg/dL · Jul 10 LAB: 70–99 · above ref (posture) · H Guideline: not wired Risk v1: 95–114.99 · governed v1 band · 0.20 History: No observed history | 104 mg/dL · Jul 10 | 70–99Habove ref (posture) | not wired | 95–114.99.20 | — |
HomocysteineHomocysteineLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Fasting insulinFasting insulinLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history Notes: Clinical validation pending · scoring validation pending. | Never observed | — | — | not in v1 score output | — |
| Lipids & cardiometabolic4/5 observed1 gapsGL 1Risk 3/4 | |||||
Total cholesterolTotal cholesterolLatest: 204 mg/dL · Jul 10 · Verve EHR LAB: above ref (posture) Guideline: not wired Risk v1: 180–259.99 · governed v1 band · 0.00 History: May 2, 2024 · 208 mg/dL → Jul 2, 2025 · 212 mg/dL → Jul 10 · 204 mg/dL | 204 mg/dL · Jul 10 · Verve | above ref (posture) | not wired | 180–259.99.00 | 3 |
LDL cholesterolLDL cholesterolLatest: 118 mg/dL · Jul 10 · Verve EHR LAB: <100 · above ref (posture) · H Guideline: not wired Risk v1: 100–119.99 · governed v1 band · 0.10 History: Jul 2, 2025 · 131 mg/dL → Jul 10 · 118 mg/dL | 118 mg/dL · Jul 10 · Verve | <100Habove ref (posture) | not wired | 100–119.99.10 | 2 |
HDL cholesterolHDL cholesterolLatest: 44 mg/dL · Jul 10 · Verve EHR LAB: >40 · within ref Guideline: not wired Risk v1: 40–44.99 · governed v1 band · 0.20 History: May 2, 2024 · 45 mg/dL → Jul 2, 2025 · 42 mg/dL → Jul 10 · 44 mg/dL | 44 mg/dL · Jul 10 · Verve | >40within ref | not wired | 40–44.99.20 | 3 |
TriglyceridesTriglyceridesLatest: 168 mg/dL · Jul 10 · Verve EHR LAB: <150 · above ref (posture) · H Guideline: above threshold Risk v1: 150–199.99 · governed v1 band · 0.30 History: May 2, 2024 · 181 mg/dL → Jul 2, 2025 · 154 mg/dL → Jul 10 · 168 mg/dL | 168 mg/dL · Jul 10 · Verve | <150Habove ref (posture) | above threshold | 150–199.99.30 | 3 |
Lp(a) / Lipoprotein(a)Lp(a) / Lipoprotein(a)Latest: Source unavailable LAB: unavailable Guideline: unavailable Risk v1: not in v1 score output History: No observed history Notes: Approved universal member; no connected source. Cadence once_in_adulthood is the only governed cadence in the contract — a baseline satisfaction rule, not a bar to governed repeat testing. Never rendered as normal. | Source unavailable | unavailable | unavailable | not in v1 score output | — |
| Hepatic7/7 observed0 gapsGL 0Risk 3/7 | |||||
ALTALTLatest: 31 U/L · Jul 10 LAB: within ref Guideline: not wired Risk v1: 29–49.99 · governed v1 band · 0.20 History: No observed history | 31 U/L · Jul 10 | within ref | not wired | 29–49.99.20 | — |
ASTASTLatest: 27 U/L · Jul 10 LAB: within ref Guideline: not wired Risk v1: 26–34.99 · governed v1 band · 0.10 History: No observed history | 27 U/L · Jul 10 | within ref | not wired | 26–34.99.10 | — |
AlbuminAlbuminLatest: 4.3 g/dL · Jul 10 LAB: within ref Guideline: not wired Risk v1: 4–4.99 · governed v1 band · 0.00 History: No observed history Notes: Mapping posture pending — the marker identity is not promoted yet. | 4.3 g/dL · Jul 10 | within ref | not wired | 4–4.99.00 | — |
Alkaline phosphataseAlkaline phosphataseLatest: 78 U/L · Jul 10 LAB: within ref Guideline: not wired Risk v1: 70–99.99 · governed v1 band · 0.00 History: No observed history | 78 U/L · Jul 10 | within ref | not wired | 70–99.99.00 | — |
Bilirubin, totalBilirubin, totalLatest: 0.7 mg/dL · Jul 10 LAB: within ref Guideline: not wired Risk v1: 0.1–1.29 · governed v1 band · 0.00 History: No observed history | 0.7 mg/dL · Jul 10 | within ref | not wired | 0.1–1.29.00 | — |
GGTGGTLatest: 41 U/L · Jul 10 LAB: 8–71 · within ref Guideline: not wired Risk v1: 25.01–50 · governed v1 band · 0.20 History: No observed history | 41 U/L · Jul 10 | 8–71within ref | not wired | 25.01–50.20 | — |
Total proteinTotal proteinLatest: 7.1 g/dL · Jul 10 LAB: within ref Guideline: not wired Risk v1: 6.9–7.390000000000001 · governed v1 band · 0.00 History: No observed history | 7.1 g/dL · Jul 10 | within ref | not wired | 6.9–7.390000000000001.00 | — |
| Renal & electrolytes8/10 observed2 gapsGL 0Risk 2/7 | |||||
CreatinineCreatinineLatest: 1.1 mg/dL · Feb 10, 2023 · Marathon lab LAB: within ref Guideline: not wired Risk v1: 1.1–1.49 · governed v1 band · 0.10 History: Mar 4, 2022 · 1.0 mg/dL → Feb 10, 2023 · 1.1 mg/dL Notes: Not classified stale — cadence governance is pending for this item. | 1.1 mg/dL · Feb 10, 2023 · Marathon | within ref | not wired | 1.1–1.49.10 | 2 |
eGFReGFRLatest: value present, unmapped · Feb 10, 2023 LAB: unavailable Guideline: unavailable Risk v1: excluded — unmapped observation History: No observed history Notes: CKD-EPI 2021 LOINC drift — a named limitation resolved by a future panel version, never by widening the standard 18 in place. | Unmapped · value present, unmapped · Feb 10, 2023 | unavailable | unavailable | excluded — unmapped observation | — |
BUNBUNLatest: 16 mg/dL · Jul 10 LAB: within ref Guideline: not wired Risk v1: 16–24.99 · governed v1 band · 0.10 History: No observed history | 16 mg/dL · Jul 10 | within ref | not wired | 16–24.99.10 | — |
SodiumSodiumLatest: 139 mmol/L · Jul 10 LAB: within ref Guideline: not wired Risk v1: 135–141.99 · governed v1 band · 0.00 History: No observed history | 139 mmol/L · Jul 10 | within ref | not wired | 135–141.99.00 | — |
PotassiumPotassiumLatest: 4.2 mmol/L · Jul 10 LAB: within ref Guideline: not wired Risk v1: 4–4.49 · governed v1 band · 0.00 History: No observed history | 4.2 mmol/L · Jul 10 | within ref | not wired | 4–4.49.00 | — |
CalciumCalciumLatest: 9.4 mg/dL · Jul 10 LAB: within ref Guideline: not wired Risk v1: 9.2–9.99 · governed v1 band · 0.00 History: No observed history | 9.4 mg/dL · Jul 10 | within ref | not wired | 9.2–9.99.00 | — |
Bicarbonate / CO₂Bicarbonate / CO₂Latest: 25 mmol/L · Jul 10 LAB: within ref Guideline: not wired Risk v1: 25–29.99 · governed v1 band · 0.00 History: No observed history | 25 mmol/L · Jul 10 | within ref | not wired | 25–29.99.00 | — |
ChlorideChlorideLatest: 102 mmol/L · Jul 10 LAB: within ref Guideline: not wired Risk v1: 101–106.99 · governed v1 band · 0.00 History: No observed history | 102 mmol/L · Jul 10 | within ref | not wired | 101–106.99.00 | — |
MagnesiumMagnesiumLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Uric acidUric acidLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
| Hematologic7/14 observed7 gapsGL 0Risk 1/4 | |||||
HemoglobinHemoglobinLatest: 13.8 g/dL · Jul 10 LAB: within ref Guideline: not wired Risk v1: excluded — model identity unresolved History: No observed history | 13.8 g/dL · Jul 10 | within ref | not wired | excluded — model identity unresolved | — |
WBCWBCLatest: 6.4 K/µL · Jul 10 LAB: within ref Guideline: not wired Risk v1: 5.7–6.49 · governed v1 band · 0.10 History: No observed history | 6.4 K/µL · Jul 10 | within ref | not wired | 5.7–6.49.10 | — |
PlateletsPlateletsLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history Notes: Expected standard-18 item with no observed result — an unknown, not a normal platelet count. | Never observed | — | — | not in v1 score output | — |
HematocritHematocritLatest: 41.2 % · Jul 10 LAB: within ref Guideline: not wired Risk v1: 39–45.99 · governed v1 band · 0.00 History: No observed history | 41.2 % · Jul 10 | within ref | not wired | 39–45.99.00 | — |
RBCRBCLatest: 4.6 M/µL · Jul 10 LAB: within ref Guideline: not wired Risk v1: excluded — model identity unresolved History: No observed history | 4.6 M/µL · Jul 10 | within ref | not wired | excluded — model identity unresolved | — |
MCVMCVLatest: 89 fL · Jul 10 LAB: within ref Guideline: not wired Risk v1: excluded — model identity unresolved History: No observed history | 89 fL · Jul 10 | within ref | not wired | excluded — model identity unresolved | — |
MCHMCHLatest: 30.0 pg · Jul 10 LAB: within ref Guideline: not wired Risk v1: 27–31.99 · governed v1 band · 0.00 History: No observed history | 30.0 pg · Jul 10 | within ref | not wired | 27–31.99.00 | — |
MCHCMCHCLatest: 33.5 g/dL · Jul 10 LAB: within ref Guideline: not wired Risk v1: 32–34.99 · governed v1 band · 0.00 History: No observed history | 33.5 g/dL · Jul 10 | within ref | not wired | 32–34.99.00 | — |
RDWRDWLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Neutrophils, absoluteNeutrophils, absoluteLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Lymphocytes, absoluteLymphocytes, absoluteLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Monocytes, absoluteMonocytes, absoluteLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Eosinophils, absoluteEosinophils, absoluteLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Basophils, absoluteBasophils, absoluteLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
| Iron studies0/4 observed4 gapsGL 0Risk 0/0 | |||||
IronIronLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
FerritinFerritinLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
TIBCTIBCLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
Transferrin saturationTransferrin saturationLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
| Thyroid & endocrine1/2 observed1 gapsGL 0Risk 0/0 | |||||
TSHTSHLatest: 2.4 / 3.9 mIU/L · Jul 10 · Verve EHR LAB: not evaluable Guideline: not wired Risk v1: excluded — conflicted observation History: Jul 10 · 3.9 mIU/L → Jul 10 · 2.4 mIU/L Notes: Two source values on the same day. Conflicted evidence contributes to observed coverage and never resolves itself into one value on the reading surface. · conflicted — a second source value of 3.9 carries the same date · conflicted — two same-day source values, kept distinct | Conflicted · 2 values · Jul 10 | not evaluable | not wired | excluded — conflicted observation | 2 sources |
Free T4Free T4Latest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
| Nutrient0/3 observed3 gapsGL 0Risk 0/0 | |||||
Vitamin D, 25-OHVitamin D, 25-OHLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history Notes: Expected standard-18 item, never observed for this person — an important unknown, not a normal vitamin D level. | Never observed | — | — | not in v1 score output | — |
Vitamin B12Vitamin B12Latest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
FolateFolateLatest: Never observed LAB: — Guideline: — Risk v1: not in v1 score output History: No observed history | Never observed | — | — | not in v1 score output | — |
| Inflammation1/1 observed0 gapsGL 1Risk 1/1 | |||||
hsCRPhsCRPLatest: 3.4 mg/L · Jul 2 · Verve EHR LAB: not flagged (source-quiet) Guideline: above hs-CV threshold Risk v1: 3.01–6 · governed v1 band · 0.50 History: Jun 30, 2025 · 4.1 mg/L → Jul 2 · 3.4 mg/L Notes: Source-quiet but guideline-flagged: the lab did not flag it and the guideline lens did. Both render. · duplicate observation key on 2025-06-30 — row vs distinct posture shown, never silently collapsed | 3.4 mg/L · Jul 2 · Verve | not flagged (source-quiet) | above hs-CV threshold | 3.01–6.50 | 2 |
| Medication evidence1/1 observed0 gapsGL 0Risk 0/0 | |||||
Medication-evidence presenceMedication-evidence presenceLatest: present · 2 current-candidate orders · Jun 30 LAB: n/a Guideline: n/a Risk v1: not in v1 score output History: No observed history Notes: Presence, not adherence. No adherence evidence exists for this person. | present · 2 current-candidate orders · Jun 30 | n/a | n/a | not in v1 score output | — |
| Conditional expected — outside the applicable denominator0/3 observed3 gapsGL 0Risk 0/0 | |||||
uACR / albumin-creatinine ratiouACR / albumin-creatinine ratioLatest: Applicability pending LAB: available Guideline: available Risk v1: not in v1 score output History: No observed history Notes: Source available at low volume. Counted neither applicable nor not-applicable until its governed applicability rule is ratified. | Applicability pending | available | available | not in v1 score output | — |
ApoBApoBLatest: Applicability pending LAB: unavailable Guideline: unavailable Risk v1: not in v1 score output History: No observed history Notes: Approved conditional member with no connected source and no governed applicability rule. | Applicability pending | unavailable | unavailable | not in v1 score output | — |
Cystatin CCystatin CLatest: Applicability pending LAB: unavailable Guideline: unavailable Risk v1: not in v1 score output History: No observed history Notes: Approved conditional member with no connected source and no governed applicability rule. | Applicability pending | unavailable | unavailable | not in v1 score output | — |
Item states reconcile to the measures above: 32 observed — recency not classifiable · 1 observed — unmapped · 1 conflicted · 20 never observed · 1 source unavailable = 55. Cadence governance is pending for every item except Lp(a), so no item here is aging, stale, part of current completeness, a care gap, an overdue test, or a follow-up implication. Clinical and scoring validation are ratified for the standard 18 only. Foundational Risk Index v1 is a reviewed, internal-only prioritization index, not an outcome probability or validated clinical instrument. It scores each current observation only when its governed identity, normalized value/unit posture, and exactly one Min–MaxAdj band resolve. Unmapped, conflicted, unit-blocked, or range-undefined observations are excluded rather than treated as zero. Domain risk is the highest scored marker in that domain; person risk is the mean of scored domain maxima. Depth and Standard-18 remain separate evidence measures. Missing items are unknowns and never render as normal.
| Entity | Relationship | From | To | Posture |
|---|---|---|---|---|
| Northstar Fabrication | primary member | 2021-03-01 | present | current |
| Marathon group | eligibility | 2019-06-01 | 2021-02-28 | historical |
| Fact | Value | Definition | Window & rule | Null meaning | Truth posture | Evidence |
|---|---|---|---|---|---|---|
| Verified encounters, trailing 365 days | 3 | count of note-backed verified encounters with a service date in the trailing 365 days | T365 to as_of | zero means no verified encounter, not no care | DERIVED-NOT-VALIDATED | the three encounters in the encounter ledger |
| Foundational observed coverage | 62% (34/55) | foundational.observed_coverage.v1 — observed items over the applicable denominator | all manifested history | a low percentage means little is known, never that the person is healthy | REVIEW-REQUIRED | the 55-row baseline matrix and its item states |
| Observed risk posture | action tier | risk tri-state over governed marker flags; the numeric score is suppressed | current | unscored means no governed finding was observed, never low risk | REVIEW-REQUIRED — scoring-identity divergence; lab-observed evidence is the stronger spine | the marker-level findings in the baseline and lab sections |
| Precision/L3 findings | 2 | count of item-level precision findings, each carrying its own marker evidence | all manifested history | zero means no item-level finding, not an absence of risk | REVIEWED-NOT-YET-EVIDENCE-VALIDATED · internal only | A1c and hsCRP marker rows |
| Subject | Kind | What it means for the reading above |
|---|---|---|
| TSH | conflicted values | two source values carry the same collection date; both are kept distinct and neither is promoted over the other |
| eGFR | unmapped | CKD-EPI 2021 LOINC 98979-8 drift — the value is observed but cannot be interpreted until mapping promotes |
| Identity | open conflict | 1 open identity conflict (0 high) — worked in Model & Data Controls, never on this reading surface |
| hsCRP | duplicate observation key | the upstream lab feed duplicates the 2025-06-30 observation; row grain and distinct-observation grain both render |
No real data is loaded. Local mode is test-only and cannot serve an exported production snapshot. Row built Oct 14. Source Manifest PPSM-1.0 (frozen) · baseline contract foundational-baseline-v1 (ratified 2026-07-25).